Interferon-alpha-2a as a salvage treatment for hemorrhagic enteritis associated with Epstein-Barr Virus reactivation : a case report

被引：1

作者：

Lankenau-Vela, D. ^{[1
,2
]}

De la Garza-Salazar, F. ^{[1
,2
]}

Colunga-Pedraza, P. ^{[3
]}

Jaime-Villalon, D. ^{[4
]}

机构：

[1] Univ Monterrey, Especialidades Med, Escuela Med, Monterrey, Nuevo Leon, Mexico

[2] Hosp Christus Muguerza Alta Especialidad, Dept Med Interna, Monterrey, Nuevo Leon, Mexico

[3] Univ Autonoma Nuevo Leon, Hosp Univ Dr Jose Eleuterio Gonzalez, Hematol Serv, Monterrey, Mexico

[4] Hosp Christus Muguerza Alta Especialidad, Infectol Serv, Monterrey, Nuevo Leon, Mexico

来源：

ACTA GASTRO-ENTEROLOGICA BELGICA | 2021年 / 84卷 / 01期

关键词：

Epstein-barr virus reactivation; interferon; hemorrhagic enteritis; case report; THERAPY; ALPHA; INFECTION;

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Epstein-Barr virus [EBV] is a virus that infects almost all humans worldwide. After the acute phase of the infection, it stays in a latent form in B lymphocytes. EBV reactivation tends to occur in immunosuppressed patients. EBV reactivation may involve the gastrointestinal tract; it has been associated mainly with colitis, but hemorrhagic enteritis has been poorly reported. Treatment usually includes antivirals. However, our patient did not respond to conventional treatment, so interferon alpha-2a was given as a salvage treatment. To our knowledge, this is the first reported case of hemorrhagic enteritis associated to EBV reactivation treated successfully with interferon alpha-2a.

引用

页码：129 / 130

页数：2

共 12 条

[1]

Busschaert J, 2019, ACTA GASTRO-ENT BELG, V82, P552

[2] MAJOR THERAPEUTIC USES OF INTERFERONS [J].

CIRELLI, R ;

TYRING, SK .

CLINICAL IMMUNOTHERAPEUTICS, 1995, 3 (01) :27-87

[3] Epstein-Barr virus lytic reactivation regulation and its pathogenic role in carcinogenesis [J].

Li, Hongde ;

Liu, Sufang ;

Hu, Jianmin ;

Luo, Xiangjian ;

Li, Namei ;

Bode, Ann M. ;

Cao, Ya .

INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES, 2016, 12 (11) :1309-1318

[4]

Matsumoto Hiroshi, 2014, Case Rep Gastroenterol, V8, P240, DOI 10.1159/000365546

[5]

Pico, 1998, Oncologist, V3, P446

[6] Interferon alpha as antiviral therapy in chronic active Epstein-Barr virus disease with interstitial pneumonia - case report [J].

Rolinski, Jacek ;

Grywalska, Ewelina ;

Pyzik, Aleksandra ;

Dzik, Michal ;

Opoka-Winiarska, Violetta ;

Surdacka, Agata ;

Maj, Maciej ;

Burdan, Franciszek ;

Pirozynski, Michal ;

Grabarczyk, Piotr ;

Staroslawska, Elzbieta .

BMC INFECTIOUS DISEASES, 2018, 18

[7] Epstein-Barr Virus Infection Is Common in Inflamed Gastrointestinal Mucosa [J].

Ryan, Julie L. ;

Shen, You-Jun ;

Morgan, Douglas R. ;

Thorne, Leigh B. ;

Kenney, Shannon C. ;

Dominguez, Ricardo L. ;

Gulley, Margaret L. .

DIGESTIVE DISEASES AND SCIENCES, 2012, 57 (07) :1887-1898

[8] Interferon-α therapy for chronic active Epstein-Barr virus infection:: Potential effect on the development of T-lymphoproliferative disease [J].

Sakai, Y ;

Ohga, S ;

Tonegawa, Y ;

Takada, H ;

Nakao, F ;

Nakayama, H ;

Aoki, T ;

Yamamori, S ;

Hara, T .

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1998, 20 (04) :342-346

[9]

Sarwari Nawid M, 2016, BMC Hematol, V16, P19, DOI 10.1186/s12878-016-0059-3

[10] Epstein-Barr virus-associated enteritis with multiple ulcers after stem cell transplantation: First histologically confirmed case [J].

Tashiro, Yukie ;

Goto, Masamichi ;

Takemoto, Yoshinobu ;

Sato, Eiichi ;

Shirahama, Hiroshi ;

Utsunomiya, Atae ;

Eizuru, Yoshito ;

Yonezawa, Suguru .

PATHOLOGY INTERNATIONAL, 2006, 56 (09) :530-537

← 1 2 →